Global Specialty Drug Distribution Market Analysis and Forecast 2024-2030

Global Specialty Drug Distribution Market Analysis and Forecast 2024-2030


Summary

Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.

According to APO Research, The global Specialty Drug Distribution market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Specialty Drug Distribution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Specialty Drug Distribution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Specialty Drug Distribution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Specialty Drug Distribution is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Specialty Drug Distribution include AmerisourceBergen, Mckesson, Cardinal Health, Phoenix, Medipal Holdings, Alliance Healthcare, Sinopharm, Express Scripts and Shanghai Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Specialty Drug Distribution, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Specialty Drug Distribution, also provides the revenue of main regions and countries. Of the upcoming market potential for Specialty Drug Distribution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Specialty Drug Distribution revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Specialty Drug Distribution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Specialty Drug Distribution revenue, projected growth trends, production technology, application and end-user industry.

Specialty Drug Distribution segment by Company

AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma
Specialty Drug Distribution segment by Type

Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Specialty Drug Distribution segment by Application

Hospital and Clinic
Pharmacy
Others
Specialty Drug Distribution segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specialty Drug Distribution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Specialty Drug Distribution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specialty Drug Distribution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Specialty Drug Distribution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Specialty Drug Distribution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Specialty Drug Distribution revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Specialty Drug Distribution Market by Type
1.2.1 Global Specialty Drug Distribution Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oncology
1.2.3 Rheumatoid Arthritis
1.2.4 Multiple Sclerosis
1.2.5 Hemophilia
1.2.6 Others
1.3 Specialty Drug Distribution Market by Application
1.3.1 Global Specialty Drug Distribution Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital and Clinic
1.3.3 Pharmacy
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Specialty Drug Distribution Market Dynamics
2.1 Specialty Drug Distribution Industry Trends
2.2 Specialty Drug Distribution Industry Drivers
2.3 Specialty Drug Distribution Industry Opportunities and Challenges
2.4 Specialty Drug Distribution Industry Restraints
3 Global Growth Perspective
3.1 Global Specialty Drug Distribution Market Perspective (2019-2030)
3.2 Global Specialty Drug Distribution Growth Trends by Region
3.2.1 Global Specialty Drug Distribution Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Specialty Drug Distribution Market Size by Region (2019-2024)
3.2.3 Global Specialty Drug Distribution Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Specialty Drug Distribution Revenue by Players
4.1.1 Global Specialty Drug Distribution Revenue by Players (2019-2024)
4.1.2 Global Specialty Drug Distribution Revenue Market Share by Players (2019-2024)
4.1.3 Global Specialty Drug Distribution Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Specialty Drug Distribution Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Specialty Drug Distribution Key Players Headquarters & Area Served
4.4 Global Specialty Drug Distribution Players, Product Type & Application
4.5 Global Specialty Drug Distribution Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Specialty Drug Distribution Market CR5 and HHI
4.6.2 Global Top 5 and 10 Specialty Drug Distribution Players Market Share by Revenue in 2023
4.6.3 2023 Specialty Drug Distribution Tier 1, Tier 2, and Tier 3
5 Specialty Drug Distribution Market Size by Type
5.1 Global Specialty Drug Distribution Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Specialty Drug Distribution Revenue by Type (2019-2030)
5.3 Global Specialty Drug Distribution Revenue Market Share by Type (2019-2030)
6 Specialty Drug Distribution Market Size by Application
6.1 Global Specialty Drug Distribution Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Specialty Drug Distribution Revenue by Application (2019-2030)
6.3 Global Specialty Drug Distribution Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 AmerisourceBergen
7.1.1 AmerisourceBergen Comapny Information
7.1.2 AmerisourceBergen Business Overview
7.1.3 AmerisourceBergen Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.1.4 AmerisourceBergen Specialty Drug Distribution Product Portfolio
7.1.5 AmerisourceBergen Recent Developments
7.2 Mckesson
7.2.1 Mckesson Comapny Information
7.2.2 Mckesson Business Overview
7.2.3 Mckesson Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.2.4 Mckesson Specialty Drug Distribution Product Portfolio
7.2.5 Mckesson Recent Developments
7.3 Cardinal Health
7.3.1 Cardinal Health Comapny Information
7.3.2 Cardinal Health Business Overview
7.3.3 Cardinal Health Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.3.4 Cardinal Health Specialty Drug Distribution Product Portfolio
7.3.5 Cardinal Health Recent Developments
7.4 Phoenix
7.4.1 Phoenix Comapny Information
7.4.2 Phoenix Business Overview
7.4.3 Phoenix Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.4.4 Phoenix Specialty Drug Distribution Product Portfolio
7.4.5 Phoenix Recent Developments
7.5 Medipal Holdings
7.5.1 Medipal Holdings Comapny Information
7.5.2 Medipal Holdings Business Overview
7.5.3 Medipal Holdings Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.5.4 Medipal Holdings Specialty Drug Distribution Product Portfolio
7.5.5 Medipal Holdings Recent Developments
7.6 Alliance Healthcare
7.6.1 Alliance Healthcare Comapny Information
7.6.2 Alliance Healthcare Business Overview
7.6.3 Alliance Healthcare Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.6.4 Alliance Healthcare Specialty Drug Distribution Product Portfolio
7.6.5 Alliance Healthcare Recent Developments
7.7 Sinopharm
7.7.1 Sinopharm Comapny Information
7.7.2 Sinopharm Business Overview
7.7.3 Sinopharm Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.7.4 Sinopharm Specialty Drug Distribution Product Portfolio
7.7.5 Sinopharm Recent Developments
7.8 Express Scripts
7.8.1 Express Scripts Comapny Information
7.8.2 Express Scripts Business Overview
7.8.3 Express Scripts Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.8.4 Express Scripts Specialty Drug Distribution Product Portfolio
7.8.5 Express Scripts Recent Developments
7.9 Shanghai Pharma
7.9.1 Shanghai Pharma Comapny Information
7.9.2 Shanghai Pharma Business Overview
7.9.3 Shanghai Pharma Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.9.4 Shanghai Pharma Specialty Drug Distribution Product Portfolio
7.9.5 Shanghai Pharma Recent Developments
7.10 Anda
7.10.1 Anda Comapny Information
7.10.2 Anda Business Overview
7.10.3 Anda Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.10.4 Anda Specialty Drug Distribution Product Portfolio
7.10.5 Anda Recent Developments
7.11 Jointown
7.11.1 Jointown Comapny Information
7.11.2 Jointown Business Overview
7.11.3 Jointown Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.11.4 Jointown Specialty Drug Distribution Product Portfolio
7.11.5 Jointown Recent Developments
7.12 Max Pharma
7.12.1 Max Pharma Comapny Information
7.12.2 Max Pharma Business Overview
7.12.3 Max Pharma Specialty Drug Distribution Revenue and Gross Margin (2019-2024)
7.12.4 Max Pharma Specialty Drug Distribution Product Portfolio
7.12.5 Max Pharma Recent Developments
8 North America
8.1 North America Specialty Drug Distribution Revenue (2019-2030)
8.2 North America Specialty Drug Distribution Revenue by Type (2019-2030)
8.2.1 North America Specialty Drug Distribution Revenue by Type (2019-2024)
8.2.2 North America Specialty Drug Distribution Revenue by Type (2025-2030)
8.3 North America Specialty Drug Distribution Revenue Share by Type (2019-2030)
8.4 North America Specialty Drug Distribution Revenue by Application (2019-2030)
8.4.1 North America Specialty Drug Distribution Revenue by Application (2019-2024)
8.4.2 North America Specialty Drug Distribution Revenue by Application (2025-2030)
8.5 North America Specialty Drug Distribution Revenue Share by Application (2019-2030)
8.6 North America Specialty Drug Distribution Revenue by Country
8.6.1 North America Specialty Drug Distribution Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Specialty Drug Distribution Revenue by Country (2019-2024)
8.6.3 North America Specialty Drug Distribution Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Specialty Drug Distribution Revenue (2019-2030)
9.2 Europe Specialty Drug Distribution Revenue by Type (2019-2030)
9.2.1 Europe Specialty Drug Distribution Revenue by Type (2019-2024)
9.2.2 Europe Specialty Drug Distribution Revenue by Type (2025-2030)
9.3 Europe Specialty Drug Distribution Revenue Share by Type (2019-2030)
9.4 Europe Specialty Drug Distribution Revenue by Application (2019-2030)
9.4.1 Europe Specialty Drug Distribution Revenue by Application (2019-2024)
9.4.2 Europe Specialty Drug Distribution Revenue by Application (2025-2030)
9.5 Europe Specialty Drug Distribution Revenue Share by Application (2019-2030)
9.6 Europe Specialty Drug Distribution Revenue by Country
9.6.1 Europe Specialty Drug Distribution Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Specialty Drug Distribution Revenue by Country (2019-2024)
9.6.3 Europe Specialty Drug Distribution Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Specialty Drug Distribution Revenue (2019-2030)
10.2 China Specialty Drug Distribution Revenue by Type (2019-2030)
10.2.1 China Specialty Drug Distribution Revenue by Type (2019-2024)
10.2.2 China Specialty Drug Distribution Revenue by Type (2025-2030)
10.3 China Specialty Drug Distribution Revenue Share by Type (2019-2030)
10.4 China Specialty Drug Distribution Revenue by Application (2019-2030)
10.4.1 China Specialty Drug Distribution Revenue by Application (2019-2024)
10.4.2 China Specialty Drug Distribution Revenue by Application (2025-2030)
10.5 China Specialty Drug Distribution Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Specialty Drug Distribution Revenue (2019-2030)
11.2 Asia Specialty Drug Distribution Revenue by Type (2019-2030)
11.2.1 Asia Specialty Drug Distribution Revenue by Type (2019-2024)
11.2.2 Asia Specialty Drug Distribution Revenue by Type (2025-2030)
11.3 Asia Specialty Drug Distribution Revenue Share by Type (2019-2030)
11.4 Asia Specialty Drug Distribution Revenue by Application (2019-2030)
11.4.1 Asia Specialty Drug Distribution Revenue by Application (2019-2024)
11.4.2 Asia Specialty Drug Distribution Revenue by Application (2025-2030)
11.5 Asia Specialty Drug Distribution Revenue Share by Application (2019-2030)
11.6 Asia Specialty Drug Distribution Revenue by Country
11.6.1 Asia Specialty Drug Distribution Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Specialty Drug Distribution Revenue by Country (2019-2024)
11.6.3 Asia Specialty Drug Distribution Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Specialty Drug Distribution Revenue (2019-2030)
12.2 MEALA Specialty Drug Distribution Revenue by Type (2019-2030)
12.2.1 MEALA Specialty Drug Distribution Revenue by Type (2019-2024)
12.2.2 MEALA Specialty Drug Distribution Revenue by Type (2025-2030)
12.3 MEALA Specialty Drug Distribution Revenue Share by Type (2019-2030)
12.4 MEALA Specialty Drug Distribution Revenue by Application (2019-2030)
12.4.1 MEALA Specialty Drug Distribution Revenue by Application (2019-2024)
12.4.2 MEALA Specialty Drug Distribution Revenue by Application (2025-2030)
12.5 MEALA Specialty Drug Distribution Revenue Share by Application (2019-2030)
12.6 MEALA Specialty Drug Distribution Revenue by Country
12.6.1 MEALA Specialty Drug Distribution Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Specialty Drug Distribution Revenue by Country (2019-2024)
12.6.3 MEALA Specialty Drug Distribution Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings